All software research
LIMS · profile

Agilent SLIMS

Sourced profiles of MES, QMS and LIMS products. Dataset as of 2026-10-04.

Vendor
Agilent
Category
LIMS (vendor also describes ELN and LES in the same product)
Deployment
On premise, cloud hosted by Agilent, or cloud hosted by the customer.
Pricing stance
Quote-only
Regulatory posture
Vendor: technical controls for labs that must follow 21 CFR Part 11, EU Annex 11, and GAMP 5. Not a certificate. Same product is also described as ELN and LES.
Independent review
Passed 2026-10-02
Sourced claims
54

Product: Agilent SLIMS ("smart" LIMS), a combined LIMS, ELN, and laboratory execution system (LES). Formerly Genohm SLIMS. Vendor: Agilent Technologies, Inc. (NYSE: A), 5301 Stevens Creek Blvd., Santa Clara, CA 95051. Acquired with Genohm (Lausanne) in 2018. Category: LIMS and lab execution software for pharma QC, biobanks, NGS, analytical, cannabis, and PFAS labs. Not an MES, CDS, or QMS. Verification date: 2026-10-02. Scope: Public web sources only.

1. Overview

Agilent SLIMS is a combined LIMS, ELN, and lab execution system that Agilent bought with Genohm in 2018, built for biobanks and NGS labs and now pitched to pharma QC through stability studies and a direct OpenLab CDS handoff. Its best-documented public buyers are FDA, whose CFSAN Genomics Information Management System (GIMS) has run on SLIMS licences since 2014, and the UK Health Security Agency, which runs it as a critical dependency in its genome-sequencing labs.

Agilent says SLIMS "combines the best of a LIMS and an ELN in a single Laboratory execution system (LES)." It tracks each sample from reception, storage, and processing through results, and runs in a web browser on a computer or tablet. (Agilent SLIMS explore page.) Agilent targets pharmaceutical labs that need compliance controls, biobanks, NGS labs, analytical labs, cannabis testing, and PFAS testing. At acquisition, SLIMS served biobanks, research labs, and NGS facilities. (EPFL-hosted announcement PDF, 2 May 2018.) Agilent says labs in more than 20 countries use it.

In one application, a lab tracks samples and locations, executes protocols, integrates instruments, keeps versioned SOPs, reviews by exception, and signs and audits records. The pharma configuration adds stability studies, a workflow module, resource and calibration control, and a chromatography handoff.

Outside SLIMS:

  • OpenLab CDS is Agilent's separate chromatography data system. SLIMS sends sequences to it and takes results back. At acquisition, Agilent's John Sadler said SLIMS's architecture is "aligned with" OpenLab. (Pharma page.)
  • iLab and the Alissa Platform (including Alissa Interpret) are separate Agilent products SLIMS connects to. (NGS page.)
  • MES, ERP, QMS, and billing are external; SAP and billing systems are named integration examples.

2. Company and product identity

Point Fact Source
Name "Smart" LIMS: SLIMS. Agilent defines an LES as LIMS plus ELN. Explore page
Genohm origins Founded in Ghent, Belgium, in 2002 as a two-person bioinformatics shop; an EPFL start-up at Innovation Park, Lausanne, from 2011. Founder and CEO Frederik Decouttere. 2 May 2018 release
Genohm at acquisition SLIMS was its main lab automation suite, a LIMS and ELN tracking samples, tests, users, results, and workflows from material shipment through instrument results and analysis pipelines, with an app marketplace of preconfigured workflows. Offices in Lausanne, Ghent, and Durham, NC; 40 employees (40+ in the boilerplate); customers in Europe, the Middle East, Asia Pacific, and the US. 2 May 2018 release
Acquisition Definitive agreement 2 May 2018; completed 14 May 2018. Terms undisclosed. Agilent bought LIMS and workflow management and broader ELN capability to give its analytical data more context. Sadler was VP and GM of Software and Informatics; Kamni Vijay, VP and GM of Genomics, tied the deal to NGS workflows. EPFL PDF; Investor release
Seller today Agilent Technologies, Santa Clara. In the UK: Agilent Technologies Lda UK Limited. Pharma page; UK notices

3. Pharma and biotech relevance

Agilent pitches SLIMS to QC labs as "not just another LIMS": it covers bench execution as well as sample tracking, and can sit beside an existing LIMS or replace it. The pharma page names review by exception, signatures, an audit trail, stability studies, and instrument and material checks so only approved instruments and in-date materials are used. (Pharma page.)

  • Part 11, Annex 11, GAMP 5. SLIMS "provides the technical controls" to acquire, process, report, and store data under FDA 21 CFR Part 11, EU Annex 11, GAMP 5, ISO/IEC 17025, and EPA 40 CFR Part 160. Agilent's Part 11 / Annex 11 white paper for SLIMS is part number 5994-5125EN; a search extract of it says Agilent develops and tests SLIMS under ISO 9001:2015, performs IQ/OQ, and leaves PQ and system validation to the customer. (Explore page.)
  • Clinical NGS. Agilent says the audit history "helps you meet your 21 CFR part 11 compliance obligations" and can "streamline compliance with HIPAA, CLIA, CAP and more." (NGS page.)
  • Biobanking. SLIMS supports ISO 20387:2018, ISBER recommendations, and SPREC nomenclature, with chain of custody, consent, and freezer and EMR integration. (Biobank page.)
  • Pharma QC workflows. Stability studies (storage conditions, packaging, timepoints, specifications, trending); a workflow module that chains step outputs into later tests; barcode design; versioned SOPs; and a six-step OpenLab CDS sequence handoff. A "Biopharma QC Digital Transformation" application note and a pharma brochure are gated.

FDA's site search could not be queried on 2 Oct 2026, and web searches that day found no FDA or EMA regulatory record naming SLIMS or Genohm. FDA is itself a SLIMS buyer (section 7).

4. Capabilities

Capability Type What Agilent documents Source
Sample tracking Native Reception, storage, and processing through results; location, assignment, aliquoting, mixing, barcodes. Explore page
LIMS + ELN + LES Native Sample-centric LIMS and workflow-driven ELN in one system. Explore FAQ; pharma page
Protocol execution Native Step guidance, review by exception, signatures, audit trail, reports. Explore FAQ; pharma page
Stability Module "Stability Module": temperature, humidity, photolysis, packaging, timepoints, specifications, pull plans, trending. Pharma page
Workflow module Module One step's output feeds the next (one preparation used for both a pH test and an HPLC test); live view of who is on which task. Pharma page
SLIMS Store Content packages Sample types, locations, metadata, automation snippets, premade configurations. NGS index sets for Agilent SureSelect, Illumina Nextera XT, BGI, and 10x Genomics, plus Excel upload of custom sets. A default SureSelect XT on NovaSeq workflow deploys "in minutes." Explore, pharma, NGS pages
Instrument integration Native Results captured without retyping. Named: OpenLab CDS, TapeStation (automatic), Illumina BaseSpace, EMR plugins. Pharma, biobank, NGS pages
OpenLab CDS handoff Native Client request; sequence built in SLIMS; sent to the CDS; processed in OpenLab CDS Data Analysis; results returned without retyping; approved report to the client. Agilent also says SLIMS "can interface with any" CDS. Pharma page
Resources and calibration Native Reagents, locations, calibration, maintenance; use restricted to approved instruments and valid chemicals. Pharma page
Biobank operations Native Studies, subject registration, visits, collection events, chain of custody, configurable annotations, longitudinal timepoints, consent. Biobank page
API Native "APIs, which allow communication with third-party tools"; "Use the SLIMS API to connect" to the customer's pipeline. Explore page; NGS page
Services Service Installation, verification, configuration with the customer, validation, and training of designated users to make later changes. Explore, pharma, biobank, NGS pages

Agilent publishes no version number, database, browser list, or data-residency region.

5. Architecture and deployment

Three options: on-premises, cloud hosted by Agilent, or cloud hosted by the customer ("your favorite cloud service provider"). SaaS is supported. Deployment is "quick and 100% remote." The browser client means no client-software maintenance cost. (Explore page.) Genohm already offered on-premises and cloud versions in 2018. The architecture "scales" for data-intensive, multi-site labs across time zones. (NGS page.)

6. Integrations

Interface What Agilent documents
OpenLab CDS "Automated, secure, and easy to implement." Sequence tables go to the CDS and results return to the test protocol; instruments can be set as required or next-available.
Any CDS "SLIMS can interface with any chromatography data system (CDS)."
TapeStation Automatic connection; results flow into SLIMS.
NGS Illumina BaseSpace core workflows; SureSelect, Nextera, BGI, and 10x index sets.
Alissa Interpret Integrated in the NGS pipeline.
iLab Named integration.
EMR and freezers "Integration with freezer management systems, instruments, and hospital EMR systems"; EMR plugins. No EMR vendor named.
SAP, billing, identity "Many business packages (such as identify management software, SAP, or billing systems)."
API Open API to third-party tools and pipelines. A third-party catalog (APIs.io) says the SLIMS REST API comes with a SLIMS license.

7. Pricing and commercial model

Pricing is quote-only. Agilent publishes no SLIMS list price. Its FAQ says cost depends on number of users, functions needed, deployment method, and access, and argues for lower running cost: no client maintenance, SaaS support, Store configurations that shorten implementation, and trained users who handle routine changes without buying services. (Explore FAQ.)

UK contract terms describe the model: annual license subscriptions paid upfront per one-year period (a three-year subscription billed as three invoices), added user licenses priced at the contracted rate for the period, and services billed after delivery on time and materials under a quote and a "SLIMS Supplementary Terms & Conditions / SLIMS Cloud Software Master Agreement."

Agilent's GSA schedule GS-07F-0564X (1 June 2011 to 31 May 2026; SINs 334516 and 532490L on the cover, 531490L in the SIN table) does not list SLIMS in its August 2022 price list. (GSA PDF.) FDA nonetheless ordered a SLIMS licence renewal under that schedule in 2023 (below), so SLIMS is bought through the vehicle without a published schedule price.

Public contract records

Notice Buyer Supplier Scope Value
Contracts Finder; Sell2Wales "PHE - ICT - Agilent LIMS for Colindale (Genome) STA" (cites Contracts Finder 31682) Public Health England AGILENT TECHNOLOGIES LDA UK LIMITED "Implementation and licensing of Agilent SLIMS (lab information system) for genome sequencing"; awarded 20 May 2021, contract 21 May to 30 September 2021 £184,000 (VAT treatment not stated)
Contracts Finder; Find a Tender 2025/S 000-043798 (ocid ocds-h6vhtk-0567eb, published 29 July 2025) UK Health Security Agency (Secretary of State for Health and Social Care) Agilent Technologies Lda UK Limited "Agilent SLIMS 2025-2026 Licenses Renewal," 1 July 2025 to 30 June 2026; S-LIMS is a critical dependency for UKHSA sequencing labs £69,315.24 excluding VAT; £83,178.29 including VAT
Contracts Finder CF-1022000D0O000000rwimUAA (DPS call-off) UK Health Security Agency Insight Direct (UK) Ltd (reseller) 2022-23: "92 Named Premium Agilent SLIMS Licences, 1 Additional Agilent SLIMS Server Licence" £104,329.10
Contracts Finder CF-1755100D0O000000rwimUAA (framework call-off) UK Health Security Agency Insight Direct (UK) Ltd (reseller) 2023-24 renewal £112,807.41

None of the amounts in this section is a list price. They are award, obligation, or framework values, and none should be divided into a per-user price.

FDA (Office of Acquisitions & Grant Services; CFSAN programme): Genomics Information Management System (GIMS). FDA's 2025 sources-sought notice and RFQ state that GIMS runs on Agilent SLIMS user and server licences, and the RFQ asks to upgrade "FDA currently Agilent SLIMS version to version 6.9." Awards described only as GIMS are attributed to SLIMS through that link.

Award (USAspending) Recipient Signed Obligated (USD) Description
HHSF223201400041A Genohm Inc 2014-03-12 198,136.00 GIMS; performance to 2019-03-31 (SAM award notice FDA-SOL-14-1128885)
HHSF223201410185A Genohm Inc 2014-08-23 7,461.83 10 SLIMS user licenses, one option year
HHSF223201510362A Genohm Inc 2015-08-11 37,590.00 30 SLIMS user licenses
HHSF223201610039I (IDIQ) Genohm Inc 2016-09-13 0 on the vehicle; ceiling 6,500,000 GIMS software and services IDIQ to 2021-09-14. The ceiling is not a price paid.
HHSF22301001T Genohm Inc 2016-09-15 36,450.00 30 annual GIMS licenses (IDIQ order)
HHSF22301003T Genohm Inc 2016-09-20 63,079.86 GIMS development services
HHSF22301002T Genohm Inc 2017-07-17 43,375.50 35 SLIMS software licenses
HHSF22301004T Genohm Inc 2017-08-17 141,248.00 (187,072.00 with options) GIMS development
75F40118F01005 Genohm Inc 2018-09-13 113,475.50 GIMS DME
75F40119F19006 Genohm Inc 2019-08-15 78,205.00 CFSAN GIMS upgrade FY19
75F40121P00612 Agilent Technologies, Inc. 2021-09-21 56,108.00 GIMS and customization
75F40122P00590 Agilent Technologies Inc 2022-09-29 42,993.00 GIMS and customization
75F40123F80361 Agilent Technologies Inc 2023-09-08 90,574.00 "SLIMS LICENSES RENEWAL," ordered under GSA schedule GS07F0564X; performance to 2025-09-20
75F40125P00276 Agilent Technologies Inc 2025-09-24 119,162.26 GIMS licence renewal, support, and modernization (HHS OMAS buying centre for FDA)
75F40126P00187 Agilent Technologies Inc 2026-09-08 42,034.00 GIMS licence renewal, support, and modernization; performance 2026-09-21 to 2027-09-20

Genohm was Agilent-owned from 14 May 2018, so the two later orders still made out to Genohm Inc (13 September 2018 and 15 August 2019) are post-acquisition orders. Awards to Agilent Technologies start in 2020 (NASA, below).

FDA solicitations without amounts show the deal shape. A 2020 sole-source notice of intent to Agilent covers renewal of 35 named-user SLIMS licences plus upgrades and integration of Illumina, Pacific Biosciences, and Nanopore sequencers. A 2023 RFQ covers 15 named-user licences for 12 months, extra server licensing, and consulting hours. The June 2026 RFQ-75F40126Q00250 lists Premium (7), Standard (10), and Basic (72) named-user licences plus 2 server licences, with the price cells blank. Those are licence tier names, not prices.

NASA Shared Services Center, for NASA Ames. 80NSSC20P1206, "SLIMS SOFTWARE," USD 51,516.93, signed 28 May 2020 (SAM notice 4200730020). 80NSSC24PA527, "SLIMS SOFTWARE," USD 30,764.16, signed 14 February 2024, performance 21 January 2024 to 21 January 2025, after sole-source notice 80NSSC24859925Q.

EU TED: Département de la Drôme, France. TED 276473-2020, published 15 June 2020: supply, implementation, and maintenance of a LIMS for the departmental laboratory, including interfaces, data migration, training, and sampler tablets. Concluded 27 April 2020 with eight tenders; contractor Genohm (Lausanne); value EUR 584,955.50. SLIMS is not named, and the value also covers services and hardware.

Excluded: TED 289445-2026 (KTH). This is KTH's laboratory and research equipment framework, with 53 tenderers, one of them Agilent Technologies Sweden AB. SLIMS does not appear in it; the only "Slim" is the surname of a Merck Life Science AB contact. Its SEK 950,000,000 framework maximum is not a SLIMS price. TED 226490-2025 (Latvian dental materials) is likewise unrelated.

Questions a buyer should ask

  1. What is the license metric: named user, concurrent user, site, instrument, or module? Does the UK three-year subscription structure still apply?
  2. What does the subscription cover, and what is time-and-materials (installation, configuration, validation, integration)?
  3. Which environments (production, validation, training) are included?
  4. Agilent cloud, customer cloud, or on-prem: who holds the data, and is each a different SKU?
  5. Are OpenLab CDS, TapeStation, Alissa, and BaseSpace links included or separately licensed?
  6. What does "100% remote" deployment require from the customer?
  7. Is 5994-5125EN the Part 11 package, and is IQ/OQ a paid service?
  8. Which Store packages (NGS, stability) are in the license?
  9. Can users be added mid-term at the contracted price?
  10. If SLIMS runs beside an existing LIMS, how are the two systems' scopes split?

8. Implementation and validation support

Agilent installs SLIMS, verifies it "performs exactly as designed," configures it with the customer, and trains designated users to make later changes. There is no "big bang" cutover; the lab sets the pace. Store packages accelerate setup, and routine maintenance should not take "days of professional services." Validation is part of the engineering support. (Pharma page; Explore FAQ.) Per the white-paper extract, Agilent does IQ/OQ and the customer does PQ. No validation plan template or GAMP category is published, and Agilent's general computer-system-validation services do not name SLIMS.

doTERRA "saved over 50 hours a week by replacing paper workflows with SLIMS" (Agilent teaser; case study 5994-8360EN). (Explore page.)

9. Customer evidence

Account Evidence Limit
FDA (CFSAN GIMS) Fifteen USAspending awards 2014 to 2026 for GIMS and SLIMS licences, upgrades, and development (including a USD 6.5 million IDIQ ceiling); 2026 RFQ for Premium (7), Standard (10), and Basic (72) named-user licences plus 2 server licences. Public procurement record. Award values, not list prices.
NASA Ames (via NASA Shared Services Center) "SLIMS SOFTWARE" orders, USD 51,516.93 (2020) and USD 30,764.16 (2024). Public procurement record.
UK Health Security Agency / Public Health England £184,000 implementation and licensing for genome sequencing (2021); reseller renewals of £104,329.10 (2022-23, 92 named premium licences and 1 server licence) and £112,807.41 (2023-24) through Insight Direct; £69,315.24 renewal for 2025-26; SLIMS described as a critical dependency. Public procurement record.
Département de la Drôme laboratory (France) EUR 584,955.50 LIMS award to Genohm, 2020. Public procurement record. SLIMS not named; includes services and hardware.
doTERRA Saved over 50 hours a week replacing paper workflows. Vendor teaser.
FlyORF Unattributed biobank-page quote: SLIMS handles internal and external orders, strain-collection browsing, sample management, and billing in one system. No person or year.
Unnamed hospital SLIMS tracks samples across hospitals, links subjects, samples, protocols, and results; ELN tracks sequencing runs. Unnamed.
Unnamed biobank cohort SLIMS "selected to manage our biobank and cohort," with cross-institution access and data protection. Unnamed.
Unnamed reagent and animal lab Reagents, antibodies, and mice in one system. Unnamed.
Other explore-page quotes SLIMS as the "keystone" of operations (equipment integration, SOP repository); ELN "indispensable" for a biobank. Unnamed.

10. Competitive and third-party context

No Gartner, Forrester, IDC, or LNS evaluation of SLIMS is cited, and no trade-press or ISPE article names a SLIMS site. Within Agilent's own stack, SLIMS is the sample and lab-execution layer and OpenLab CDS is the chromatography system it hands work to.

11. Changes and renames

  • 2002: Genohm founded in Ghent. 2011: moves to EPFL Innovation Park, Lausanne.
  • 2014-03-12: FDA's first GIMS award to Genohm; FDA orders continue through 2026.
  • 2018-05-02: Agilent agrees to buy Genohm. 2018-05-14: deal completes. Genohm SLIMS becomes Agilent SLIMS.
  • 2020: NASA Ames buys SLIMS; Drôme laboratory LIMS awarded to Genohm.
  • 2021: Public Health England buys SLIMS for genome sequencing.
  • 2025: Agilent markets SLIMS as LIMS + ELN + LES with three deployment models, pharma stability, the OpenLab CDS handoff, NGS Store content, and ISO 20387 biobank support. UKHSA renews licenses for 2025-26.

12. Source library

Pages retrieved 2026-10-02. Full URL list: sources note. Every claim above is in the product's evidence set with its source, type, and confidence.

Primary pages:

Sources note

Sources: Agilent SLIMS

Sources as of 2 Oct 2026. Each entry gives the source and what it supports in the profile.

Vendor and company

Press and third parties

  • APIs.io plan catalog: Seen in search. Says API access comes with a SLIMS license and that Agilent quotes the price.

Procurement

Regulators

  • EudraGMDP description: Returned by a search for SLIMS/Genohm on ema.europa.eu. No SLIMS record identified.
Get a free API key